Ovarian Cancer Staging by MDCT

Mahrooz Malek

doi:10.5812/iranjradiol.48366

Ovarian Cancer Staging by MDCT

Mahrooz Malek ^{1
, *}

Author Information

¹ Assistant professor of Tehran University of Medical Sciences, Tehran, Iran

Article information

Iranian Journal of Radiology: 14 (Special Issue); e48366
Published Online: April 12, 2017
Article Type: Abstract
Received: December 20, 2016
Accepted: February 7, 2017
DOI: 10.5812/iranjradiol.48366

To Cite: Malek M. Ovarian Cancer Staging by MDCT, Iran J Radiol. Online ahead of Print ; 14(Special Issue):e48366. doi: 10.5812/iranjradiol.48366.

Abstract

Ovarian cancer is the most lethal gynecological cancer and about 70% of the patients are advanced stagein the time of diagnosis. Decision about management (surgical debulking versus neoadjuant chemotherapy) in ovarian cancer patients is dependent on initial staging by abdominopelvic MDCT or MRI, so, Radiologist expertise on ovarian cancer staging is very important. Involvement of mesenteric root, peritoneal implante larger than 2 cm, lymphadenopathy superior to renal hilum and implants near hepatic veins are criteria for nonresectability of ovarian cancer and radiologist must be familiar and expert on the imaging protocol and findings on MDCT for ovarian cancer staging.

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Iranian Journal of Radiology

Published by: Kowsar

Ovarian Cancer Staging by MDCT

Article information

Abstract

Full Text

Readers' Comments

Iranian Journal of Radiology

Published by: Kowsar

Ovarian Cancer Staging by MDCT

Article information

Abstract

Full Text

Share on:

Readers' Comments:

Readers' Comments